Copyright © 2009 International Society for Infectious Diseases Published by Elsevier Ltd.Objectives: The aim of this study was to evaluate the safety and immunogenicity of DTPa–HBV and Hib vaccines given mixed or separately to 360 healthy infants at 2, 4, and 6 months of age. Methods: Immune memory was assessed in lower responders (post-primary anti-PRP <0.545 μg/ml), through administration of plain polyribosylribitol phosphate (PRP) at 12–15 months. All subjects received a DTPa–HBV/Hib booster at 18–19 months. Results: One month after primary vaccination, 98% had seroprotective antibody levels against HBV and 94–97% against Hib (anti-PRP ≥ 0.15 μg/ml). A statistically significant difference between groups was observed in the proportion of ...
Objective: To evaluate the immunogenicity of the Hepatitis B and Haemophilus influenzae type b compo...
BACKGROUND: Combined vaccines are urgently needed to ensure compliance with the increasing number of...
Abstract Background Combination vaccines improve coverage, compliance and effectively introduce new ...
SummaryObjectivesThe aim of this study was to evaluate the safety and immunogenicity of DTPa–HBV and...
SummaryObjectivesThe aim of this study was to evaluate the safety and immunogenicity of DTPa–HBV and...
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis and...
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemoph...
Objectives: The aim of this open, randomised, multicentre trial was to evaluate the immunogenicity a...
Background The World Health Organization (WHO) has recommended the introduction ofhepatitis B (HB) a...
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemoph...
Immunogenicity and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated...
DTaP5-HBV-IPV-Hib (Vaxelis®) is a hexavalent combination vaccine (HV) indicated in infants and toddl...
The aim of this open, randomised, multicentre trial was to evaluate the immunogenicity and reactogen...
This study investigated the immunogenicity and safety of including a Haemophilus influenzae type b v...
Aim: Combined vaccines have an increasingly important role to play in delivering these antigens acce...
Objective: To evaluate the immunogenicity of the Hepatitis B and Haemophilus influenzae type b compo...
BACKGROUND: Combined vaccines are urgently needed to ensure compliance with the increasing number of...
Abstract Background Combination vaccines improve coverage, compliance and effectively introduce new ...
SummaryObjectivesThe aim of this study was to evaluate the safety and immunogenicity of DTPa–HBV and...
SummaryObjectivesThe aim of this study was to evaluate the safety and immunogenicity of DTPa–HBV and...
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis and...
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemoph...
Objectives: The aim of this open, randomised, multicentre trial was to evaluate the immunogenicity a...
Background The World Health Organization (WHO) has recommended the introduction ofhepatitis B (HB) a...
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemoph...
Immunogenicity and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated...
DTaP5-HBV-IPV-Hib (Vaxelis®) is a hexavalent combination vaccine (HV) indicated in infants and toddl...
The aim of this open, randomised, multicentre trial was to evaluate the immunogenicity and reactogen...
This study investigated the immunogenicity and safety of including a Haemophilus influenzae type b v...
Aim: Combined vaccines have an increasingly important role to play in delivering these antigens acce...
Objective: To evaluate the immunogenicity of the Hepatitis B and Haemophilus influenzae type b compo...
BACKGROUND: Combined vaccines are urgently needed to ensure compliance with the increasing number of...
Abstract Background Combination vaccines improve coverage, compliance and effectively introduce new ...